5Moss A J, Hall W J, Cannom D S, et al. Cardiac-resynchroniza-tion therapy for the prevention of heart-failure events [ J ]. Med, 2009,361 (14) : 1329 - 38.
6Wein S,Voskoboinik A, Wein L, et al. Extending the boundaries of cardiac resynchronization therapy : Efficacy in atrial fibrillation, New York heart association class Ⅱ, and narrow QRS heart failure patients [Jl. Card Fail,2010,16(5) : 432 -8.
7Martos R, Baugh J, Ledwidge M, et al. Diagnosis of heart failure with preserved ejection fraction : improved accuracy with the use of markers of collagen turnover [ J]. Heart Fail,2009,11 (2) : 191 - 7.
8Yan A T, Yan R T, Spinale F G, et al. Plasma matrix metallopro- teinase-9 level is correlated with left ventrieular volumes and ejec- tion fraction in patients with heart failure [ J]. Card Fail,2006,12 (7) :514 -9.
9l)aubert C, Leclercq C, Cazeau S, et al. Pacing and heart failure [ J ]. Arch Mal Coeur Vaiss, 1998,91 ( ! 1 ) : 1389 - 97.
10Bozkurt B, Mann D L. Use of biomarkers in the management of heart failure : are we there yet? [ J ]. Circulation, 2003, 107 (9) : 1231 -3.
